4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg)Peptide blend

Description

A four-component co-formulation of GHRP-2, Tesamorelin, MGF (IGF-1Ec), and Ipamorelin supplied for controlled research environments. Suitable for studies exploring GHRH-receptor, IGF-1Ec–related, and ghrelin (GHS-R1a)–receptor signaling pathways in model systems.

Composition

• • • GHRP-2: 5 mg

    • Tesamorelin: 5 mg

    • MGF (IGF-1Ec): 500 mcg

    • Ipamorelin: 2.5 mg

    • Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

4X Blend GHRP-2 (5mg) / Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg)

• • • Combined pathway evaluation of GHRH analog + IGF-1Ec–related peptide + GHS agonists (GHRP-2 and Ipamorelin) in in-vitro or ex-vivo models

    • Assay development, including chromatographic separation of four co-formulated peptides

    • Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions

    • Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• • • COA pending — third-party verification in progress

Important Notice

• • • For research use only

    • Not for human consumption

    • Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• • Manufactured in the USA in an ISO 9001–based, cGMP-aligned facility 🇺🇸

  • COA pending — third-party verification in progress

  • Lyophilized for transit stability; batch traceable

  • Tamper-evident seal; lot & test date on each vial